1380087-86-4

Basic information

• Product Name: CPI-268456
• Synonyms: CPI-268456;2-((4R)-8-chloro-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
• CAS NO: 1380087-86-4
• Molecular Formula: C20H15Cl2N3O2
• Molecular Weight: 400.258
• EINECS: 604-604-1
• Mol File: 1380087-86-4.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 649.8±55.0 °C(Predicted)
• Appearance: /
• Density: 1.49±0.1 g/cm3(Predicted)
• PKA: 16.03±0.40(Predicted)
• CAS DataBase Reference: CPI-268456(CAS DataBase Reference)
• NIST Chemistry Reference: CPI-268456(1380087-86-4)
• EPA Substance Registry System: CPI-268456(1380087-86-4)

Safety Data

• Hazardous Substances Data: 1380087-86-4(Hazardous Substances Data)

Usage

General Description

CPI-268456 is a compound primarily utilized in scientific research and is renowned for its capability as a kinase inhibitor, especially for MK2 or MAPKAPK2. Chemically, it exhibits its inhibition property by selectively and potently targeting MK2's ATP binding site. This chemical compound is generally used in vitro and in vivo tests to study the effects and pathways of MK2 in various cellular responses, including inflammation, proliferation, apoptosis, and several diseases. Therefore, it can be a potentially powerful therapeutic agent for conditions mediated by the MK2 pathway. However, the safety, efficacy, and comprehensive pharmacological properties of CPI-268456 in humans are still under investigation.